Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 5032051, 13 pages
http://dx.doi.org/10.1155/2016/5032051
Research Article

Elevated Plasma Level of Interferon-λ1 in Chronic Spontaneous Urticaria: Upregulated Expression in CD8+ and Epithelial Cells and Induction of Inflammatory Cell Accumulation

1Allergy and Clinical Immunology Research Centre, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, China
2Department of Dentistry, The Second Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, China
3Allergy and Inflammation Research Institute, The Key Immunopathology Laboratory of Guangdong Province, Shantou University Medical College, Shantou 515031, China

Received 17 March 2016; Accepted 17 May 2016

Academic Editor: Alex Kleinjan

Copyright © 2016 S. F. Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Fraser and L. Robertson, “Chronic urticaria and autoimmunity,” Skin therapy letter, vol. 18, no. 7, pp. 5–9, 2013. View at Google Scholar · View at Scopus
  2. T. W. Chang, C. Chen, C.-J. Lin, M. Metz, M. K. Church, and M. Maurer, “The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria,” Journal of Allergy and Clinical Immunology, vol. 135, no. 2, pp. 337–342, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. A. P. Kaplan and M. Greaves, “Pathogenesis of chronic urticaria,” Clinical and Experimental Allergy, vol. 39, no. 6, pp. 777–787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Ferrer, “Immunological events in chronic spontaneous urticaria,” Clinical and Translational Allergy, vol. 5, article 30, 2015. View at Publisher · View at Google Scholar
  5. J. C. Santos, C. A. de Brito, E. A. Futata et al., “Up-regulation of chemokine C–C ligand 2 (CCL2) and C–X–C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria,” Clinical & Experimental Immunology, vol. 167, no. 1, pp. 129–136, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Puxeddu, P. Italiani, P. Giungato et al., “Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria,” Cytokine, vol. 61, no. 3, pp. 741–743, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Puxeddu, F. Panza, F. Pratesi et al., “CCL5/RANTES, sVCAM-1, and sICAM-1 in chronic spontaneous urticaria,” International Archives of Allergy and Immunology, vol. 162, no. 4, pp. 330–334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Rabenhorst and K. Hartmann, “Interleukin-31: a novel diagnostic marker of allergic diseases,” Current Allergy and Asthma Reports, vol. 14, article 423, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. A. B. Kay, P. Clark, M. Maurer, and S. Ying, “Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria,” British Journal of Dermatology, vol. 172, no. 5, pp. 1294–1302, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. S. V. Kotenko, G. Gallagher, V. V. Baurin et al., “IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex,” Nature Immunology, vol. 4, no. 1, pp. 69–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Pestka, C. D. Krause, and M. R. Walter, “Interferons, interferon-like cytokines, and their receptors,” Immunological Reviews, vol. 202, pp. 8–32, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Uzé and D. Monneron, “IL-28 and IL-29: newcomers to the interferon family,” Biochimie, vol. 89, no. 6-7, pp. 729–734, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Sheppard, W. Kindsvogel, W. Xu et al., “IL-28, IL-29 and their class II cytokine receptor IL-28R,” Nature Immunology, vol. 4, no. 1, pp. 63–68, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. W. J. Jordan, J. Eskdale, S. Srinivas et al., “Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response,” Genes and Immunity, vol. 8, no. 3, pp. 254–261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. M. Coccia, M. Severa, E. Giacomini et al., “Viral infection and toll-like receptor agonists induce a differential expression of type I and λ interferons in humans plasmacytoid and monocyte-derived dendritic cells,” European Journal of Immunology, vol. 34, no. 3, pp. 796–805, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. He, T. Li, H. Chen et al., “CD14+ cell-derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation,” Allergy, vol. 66, no. 2, pp. 238–246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. He, H. Zhang, H. Chen et al., “Expression and release of IL-29 by mast cells and modulation of mast cell behavior by IL-29,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 65, no. 10, pp. 1234–1241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. M. A. Bullens, A. Decraene, E. Dilissen et al., “Type III IFN-λ mRNA expression in sputum of adult and school-aged asthmatics,” Clinical and Experimental Allergy, vol. 38, no. 9, pp. 1459–1467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Zuberbier, W. Aberer, R. Asero et al., “The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update,” Allergy, vol. 69, no. 7, pp. 868–887, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Hanifin and G. Rajka, “Diagnostic features of atopic dermatitis,” Acta Dermato-Venereologica. Supplementum, vol. 92, pp. 44–47, 1980. View at Google Scholar
  21. S. He, M. D. A. Gaça, A. R. Mceuen, and A. F. Walls, “Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells,” The Journal of Pharmacology and Experimental Therapeutics, vol. 291, no. 2, pp. 517–523, 1999. View at Google Scholar · View at Scopus
  22. S. He, A. R. McEuen, S. A. Blewett et al., “The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G,” Biochemical Pharmacology, vol. 65, no. 6, pp. 1007–1015, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. He, Q. Peng, and A. F. Walls, “Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine,” Journal of Immunology, vol. 159, no. 12, pp. 6216–6225, 1997. View at Google Scholar · View at Scopus
  24. S. R. Zamuner, J. P. Zuliani, C. M. Fernandes, J. M. Gutiérrez, and C. D. F. Pereira Teixeira, “Inflammation induced by Bothrops asper venom: release of proinflammatory cytokines and eicosanoids, and role of adhesion molecules in leukocyte infiltration,” Toxicon, vol. 46, no. 7, pp. 806–813, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Ohashi, Y. Nakai, A. Tanaka et al., “Seasonal rise in interleukin-4 during pollen season is related to seasonal rise in specific IgE for pollens but not for mites,” Acta Oto-Laryngologica, vol. 118, no. 2, pp. 243–247, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Ohshima, K. Katamura, M. Miura, H. Mikawa, and M. Mayumi, “Serum levels of interleukin 4 and soluble CD23 in children with allergic disorders,” European Journal of Pediatrics, vol. 154, no. 9, pp. 723–728, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. E. B. Lee, K. W. Kim, J. Y. Hong, H. M. Jee, M. H. Sohn, and K.-E. Kim, “Increased serum thymic stromal lymphopoietin in children with atopic dermatitis,” Pediatric Allergy and Immunology, vol. 21, no. 2, pp. e457–e460, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Augey, N. Gunera-Saad, B. Bensaid, A. Nosbaum, F. Berard, and J.-F. Nicolas, “Chronic spontaneous urticaria is not an allergic disease,” European Journal of Dermatology, vol. 21, no. 3, pp. 349–353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. H. He, C. H. Song, Z. Liu et al., “Eosinophil-derived interferon-lambda contributes to initiation of allergen-related inflammation in the intestine,” Cytokine, vol. 58, no. 2, pp. 186–192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Cugno, A. Tedeschi, R. Asero, P. L. Meroni, and A. V. Marzano, “Skin autoimmunity and blood coagulation,” Autoimmunity, vol. 43, no. 2, pp. 189–194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. V. Garmendia, M. Zabaleta, O. Aldrey et al., “Immunophenotype characteristics of peripheral blood mononuclear leukocytes of Chronic Idiopathic Urticaria patients,” Investigacion Clinica, vol. 47, no. 4, pp. 361–369, 2006. View at Google Scholar · View at Scopus
  32. R. Lyck and G. Enzmann, “The physiological roles of ICAM-1 and ICAM-2 in neutrophil migration into tissues,” Current Opinion in Hematology, vol. 22, no. 1, pp. 53–59, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Miotla, V. C. Ridger, and P. G. Hellewell, “Dominant role of L- and P-selectin in mediating CXC chemokine-induced neutrophil migration in vivo,” British Journal of Pharmacology, vol. 133, no. 4, pp. 550–556, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. A. S. Bharadwaj, L. P. Schewitz-Bowers, L. Wei, R. W. J. Lee, and J. R. Smith, “Intercellular adhesion molecule 1 mediates migration of th1 and th17 cells across human retinal vascular endothelium,” Investigative Ophthalmology and Visual Science, vol. 54, no. 10, pp. 6917–6925, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Ogawa, A. Yoshizaki, K. Yanaba et al., “The differential role of L-selectin and ICAM-1 in Th1-type and Th2-type contact hypersensitivity,” The Journal of Investigative Dermatology, vol. 130, no. 6, pp. 1558–1570, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. B. León and C. Ardavín, “Monocyte migration to inflamed skin and lymph nodes is differentially controlled by L-selectin and PSGL-1,” Blood, vol. 111, no. 6, pp. 3126–3130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Forbes, M. Hulett, R. Ahrens et al., “ICAM-1-dependent pathways regulate colonic eosinophilic inflammation,” Journal of Leukocyte Biology, vol. 80, no. 2, pp. 330–341, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Toru, T. Kinashi, C. Ra, S. Nonoyama, J.-I. Yata, and T. Nakahata, “Interleukin-4 induces homotypic aggregation of human mast cells by promoting LFA-1/ICAM-1 adhesion molecules,” Blood, vol. 89, no. 9, pp. 3296–3302, 1997. View at Google Scholar · View at Scopus